Psychiatric Bulletin (2001) 25: 194-195. doi: 10.1192/pb.25.5.194-a
© 2001 The Royal College of Psychiatrists
Psychiatric Bulletin (2001) 25: 194-195
© 2001 The Royal College of Psychiatrists
Late awareness of anaemia in a patient receiving clozapine
R. H. Davies, Consultant Psychiatrist
Ymiddiriedolaeth Gig Bro Morgannwg NHS Trust, Glanrhyd Hospital,
Bridgend, Mid Glamorgan CF31 4LN
Sir: Having read the letter by Ali and Adeyemo (Psychiatric
Bulletin, November 2000, 24, 432), showing the hazards of Clozanil
Patient Monitoring Service (CPMS) full blood count monitoring by paying too
much attention to the green status, I would like to point out
another clinically relevant and related pitfall.
One of my patients with chronic schizophrenia, aged 61, has been on
clozapine for 3 years. His blood tests were all passed as green. One day we
spotted a haemoglobin of 8.5 g on the CPMS form. His normal value had been 13
g. There had been a steady fall over 6 months that nobody had detected as the
patient was asymptomatic and the medical staff were focusing on the
prominently labelled green status.
The forms themselves did later mention that the haemoglobin was falling,
but the warning was condensed on the left side below the blood parameters at
the bottom of the form. Asterisks were not used. By contrast, however, the
status green was in block capitals in open space on the opposite
side of the page, drawing the reader's eye to it instantly. This patient has
subsequently undergone investigation and treatment for anaemia.
This is another example of a false sense of security gained by relying upon
CPMS monthly blood counts. Had they been routine local blood tests then
medical staff would have, in my view, assessed each form more thoroughly,
paying attention to more than one parameter as opposed to the solitary
concern about a fall in white cell count. The CPMS form needs to have a
different layout so as to allow for other abnormalities to be drawn to the
doctors' attention sooner.